Evidence map›Paper›PMID 42835866›Full record

ArticleFrontiers in genetics2026

From prohibition to integration: LLMs in scientific publishing.

Boris Kirov, Aleksandar Marinchev, Slavil Peykov, Vassil Galabov

Abstract read
In one paragraph

Article in Frontiers in genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Boris KirovBioInfoTech Lab, Research and Development and Innovation Consortium, Sofia, Bulgaria.
Aleksandar MarinchevBioInfoTech Lab, Research and Development and Innovation Consortium, Sofia, Bulgaria.
Slavil PeykovBioInfoTech Lab, Research and Development and Innovation Consortium, Sofia, Bulgaria.
Vassil GalabovBioInfoTech Lab, Research and Development and Innovation Consortium, Sofia, Bulgaria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The growing use of large language models (LLMs) in scientific writing has intensified debates about authorship, originality, and research integrity. Critics often argue that LLM-generated text lacks originality because it is derived from existing literature. This Perspective challenges that assumption by arguing that scientific knowledge, whether produced by humans or machines, is inherently cumulative. We argue that both researchers and LLM systems operate within inherited bodies of scientific knowledge, making intellectual leadership rather than textual production the defining criterion of authorship. Researchers remain the legitimate authors when they formulate the research question, develop the central ideas, and critically direct LLMs throughout the writing process. Beyond authorship, we argue that scientific publishing increasingly rewards procedural compliance over epistemic quality, allowing formal citation practices to substitute for conceptual coherence. Rather than undermining research integrity, LLMs offer an opportunity to restore greater emphasis on reasoning and critical evaluation. Finally, we propose integrating standardized LLM-based verification directly into journal submission systems. Automated verification of references, factual consistency, and scientific and technical integrity should precede peer review, allowing reviewers to focus on originality, scientific significance, and conceptual evaluation. Properly governed, LLMs can become not only a writing assistant but also an institutional component of scientific quality assurance.

Indexed as

artificial intelligenceepistemic integritypeer reviewresearch integrityscientific authorshipscientific publishing

Identifiers

PMID42835866
PMCPMC13638188

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.